Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Mind Medicine (MindMed) Inc
MNMD
Alternate Symbol(s):
N.MMED.WS
|
N.MMED.WA
|
N.MMED.WR
|
N.MMED
Healthcare
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen...
drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:MNMD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Comment by
Nicksonsnowboar
on Mar 03, 2022 10:26am
RE:Why so quiet on here
These gimmick sector stocks have had their run. Now it's usually 1 step forward two steps back. For eternity . If you can catch the technical upside bounce on occasion good luck
...more
(0)
•••
Trebes
X
View Profile
View Bullboard History
Post by
Trebes
on Mar 01, 2022 11:56am
Why so quiet on here
no comments for a while what's going on here
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(17)
•••
Dantheman24
X
View Profile
View Bullboard History
Comment by
Dantheman24
on Feb 10, 2022 12:28pm
RE:RE:RE:RE:RE:Breaking a $1
What were you saying again?
(17)
•••
Dantheman24
X
View Profile
View Bullboard History
Post by
Dantheman24
on Feb 10, 2022 12:27pm
Gonna see it keep rocking
Buy and hold my friends. Gonna see this at its former glory and even higher. Up up and away!
(66)
•••
Alim33
X
View Profile
View Bullboard History
Post by
Alim33
on Feb 10, 2022 9:56am
Very quiet
for a stock that is up 30% in 5 days and 18% in one month.
(66)
•••
Alim33
X
View Profile
View Bullboard History
Comment by
Alim33
on Feb 07, 2022 3:28pm
RE:Halted!
Circuit breaker! Trading again!
(5)
•••
3DThree
X
View Profile
View Bullboard History
Comment by
3DThree
on Feb 07, 2022 3:27pm
RE:Halted!
Not halted in US. SMH.
(66)
•••
Alim33
X
View Profile
View Bullboard History
Post by
Alim33
on Feb 07, 2022 3:22pm
Halted!
Halted!
(66)
•••
Alim33
X
View Profile
View Bullboard History
Post by
Alim33
on Jan 31, 2022 4:24pm
MNMD closed at $1.12 USD
which is equivalent to $1.42 CDN
(0)
•••
Lulu1010
X
View Profile
View Bullboard History
Comment by
Lulu1010
on Jan 30, 2022 1:55pm
RE:RE:The climb begins!
@Dantheman - the FDA approval is for a trial, not use, so it could be years - but agree this is a good sign. @pantano33 - your website link has nothing to do with MindMed, where you meanting to post
...more
(17)
•••
Dantheman24
X
View Profile
View Bullboard History
Post by
Dantheman24
on Jan 29, 2022 10:18am
The climb begins!
Remember, MMED's all time high was $5.99, and that was on absolutely zero FDA approval! Now we have it! And once these drug companies get FDA approval the news will continue to get better and
...more
(17)
•••
Dantheman24
X
View Profile
View Bullboard History
Comment by
Dantheman24
on Jan 27, 2022 2:29pm
RE:RE:RE:RE:RE:Breaking a $1
Perfect! Buying and holding more and more!
(16)
•••
Nicksonsnowboar
X
View Profile
View Bullboard History
Comment by
Nicksonsnowboar
on Jan 27, 2022 10:36am
RE:RE:RE:RE:Breaking a $1
Got that right it is going to break a dollar. Don't get fooled .
(17)
•••
Dantheman24
X
View Profile
View Bullboard History
Post by
Dantheman24
on Jan 26, 2022 9:38am
Nowhere but up
You'd be a fool not to buy this, fda approval for a drug company is huge. Nowhere but up! Buy and hold!
(18)
•••
maoae7
X
View Profile
View Bullboard History
Comment by
maoae7
on Jan 26, 2022 9:18am
RE:RE:RE:LSD-25
Yes cannabis is safer. More THC less tar. You don't even have to smoke it anymore. A few drop of CBD in your coffee in the morning that's it. Cannabis takes time to grow. LSD can be
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden